10X Genomics, Inc. Reagents for the Critical Care Medicine Department (CCMD)
Closed Pre-Solicitation Posted
- Solicitation number
- 25-007616
- Agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health (NIH) Clinical Center's Critical Care Medicine Department (CCMD) intends to award a firm fixed price Purchase Order to 10X Genomics, Inc. for specialized reagents supporting their Early Detection of Lung Diseases (EDLI) research project. The procurement will specifically involve five different genomic research kits, including Chromium Next GEM Chip K Single Cell Kits, Chromium Single Cell Human BCR and TCR Amplification Kits, Chromium Next GEM Single Cell 5' Kit v2, and a Library Construction Kit. The acquisition will be conducted using FAR Part 13 Simplified Acquisition Procedures, which allows for a sole source procurement when only one source is reasonably available. Interested parties capable of providing similar products may submit a capability statement by June 16, 2025, at 3:00 pm EST to Tasha Lowe, the NIH Contract Specialist. The government retains sole discretion to determine whether to compete the proposed contract based on received capability statements.
The pre-solicitation notice indicates no specific set-aside designation for this contract opportunity. The total quantity requested includes two units each of the Chromium Next GEM Chip K Single Cell Kit, Chromium Single Cell Human BCR Amplification Kit, Chromium Next GEM Single Cell 5' Kit v2, and Chromium Single Cell Human TCR Amplification Kit, plus four units of the Library Construction Kit. The place of performance will be in Bethesda, MD 20892, with the vendor being 10X Genomics, Inc., located in Pleasanton, California. The contract is specifically tailored to support precise research requirements, with the procurement emphasizing that only 10X Genomics proprietary reagents can be used to ensure equipment integrity and accurate research outcomes. The opportunity is classified under NAICS Code 325413 for In-Vitro Diagnostic Substance Manufacturing and Product Service Code 6550 for In Vitro Diagnostic Substances, Reagents, Test Kits and Sets.
Notice text
10X Genomics, Inc. Reagents for the Critical Care Medicine Department (CCMD)
- Product Service Code: 6550
- NAICS Code: 325413
- Place of Performance:
Bethesda, MD 20892
POTS: 25-007616
Description
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued, and quotations will not be requested.
The National Institutes of Health (NIH), Office of Purchasing and Contracts on behalf of the Critical Care Medicine Department (CCMD) intends to award a firm fixed price Purchase Order to 10X Genomics, Inc, located in Pleasanton, California 94588-3260 on a sole source basis to provide 10X Genomics Reagents.
The Critical Care Medicine Department is currently engaged in a project focused on the Early Detection of Lung Diseases (EDLI). The 10X Genomics Chromium 5' v2 Kit enables high-resolution gene expression profiling, immune repertoire analysis, and other advanced applications essential for identifying early biomarkers and understanding the molecular mechanisms behind both infectious and noninfectious lung diseases. The benefits of this technology have been consistently validated through multiple studies. To ensure accurate results, only proprietary reagents, consumables, and components from 10X Genomics, Inc. should be used with the existing instrumentation located within CCMD. Using incompatible reagents may damage the equipment and lead to incorrect test outcomes. To ensure the continuity and integrity of the research project, it is crucial to procure 10X Genomics reagents to support patient care.
The below items are required for this action:
Description/Product Code/Quantity:
Chromium Next GEM Chip K Single Cell Kit, 48 rxns/Product code: 1000286 Qty: 2
Chromium Single Cell Human BCR Amplification Kit, 16 rxns/Product code: 1000253 Qty: 2
Chromium™ Next GEM Single Cell 5' Kit v2, 16 rxns/Product Code: 1000263 Qty: 2
Library Construction Kit, 16 rxns - 1000190/Product Code: 1000190 Qty: 4
Chromium Single Cell Human TCR Amplification Kit, 16 rxns/ Product Code: 1000252 Qty: 2
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
Interested Parties:
Interested parties capable of providing the same or similar products or services described in this notice may submit a capability statement outlining their capability to perform the described work. Capability Statements must be received within the time set forth in this synopsis to be considered by the Government. The determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.
Comments:
Comments to this announcement, referencing this posting number on the email subject line, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Tasha Lowe Contract Specialist, lowet2@mail.nih.gov by the due date June 16, 2025, (3:00 pm EST) and time marked in this notice.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| RNA sequencing and whole genome sequencing services | Office of Logisitics and Acquisition Operations | No set-aside | |
| Reagents and consumables for Roche immunostainers | Office of Logisitics and Acquisition Operations | No set-aside | |
| Combined Synopsis Solicitation- Acquire Flow Cytom | Office of Logisitics and Acquisition Operations | No set-aside | |
| iPSC Culture and Differentiation | Office of Logisitics and Acquisition Operations | No set-aside | |
| Clinical Research Support and Collaboration for NHGRI Protocols | Office of Logisitics and Acquisition Operations | Total Small Business |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity